Cargando…

Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels

BACKGROUND: Alteration in glycosphingolipids (GSLs) in Parkinson's disease (PD) still needs to be determined. OBJECTIVES: We evaluated if PD subjects show abnormal GSLs levels compared to healthy controls (HC) and if GSLs correlate with clinical features. METHODS: We analyzed GSLs and glucosylc...

Descripción completa

Detalles Bibliográficos
Autores principales:	te Vruchte, Danielle, Sturchio, Andrea, Priestman, David A., Tsitsi, Panagiota, Hertz, Ellen, Andréasson, Mattias, Markaki, Ioanna, Wallom, Kerri‐Lee, Platt, Frances, Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286748/ https://www.ncbi.nlm.nih.gov/pubmed/35876461 http://dx.doi.org/10.1002/mds.29163

Ejemplares similares

Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
por: Wallom, Kerri-Lee, et al.
Publicado: (2021)

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
por: Green, Holly, et al.
Publicado: (2019)

Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis
por: Halter, David, et al.
Publicado: (2007)

Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease
por: Reza, Safoura, et al.
Publicado: (2021)

Neurocognitive profile of adults with the Norrbottnian type of Gaucher disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
por: Paslawski, Wojciech, et al.
Publicado: (2023)

Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of the mouse brain
por: Hallett, Penelope J., et al.
Publicado: (2018)

Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson’s disease
por: Waldthaler, Josefine, et al.
Publicado: (2019)

Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease
por: Ashe, Karen M., et al.
Publicado: (2011)

Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
por: Henriques, Alexandre, et al.
Publicado: (2015)

Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes
por: Massaro, Giulia, et al.
Publicado: (2020)

A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids
por: Durán, Anyelo, et al.
Publicado: (2023)

Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes
por: Kojima, Rika, et al.
Publicado: (2022)

Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma
por: Byrne, Frances L., et al.
Publicado: (2022)

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
por: Sundgren, Mathias, et al.
Publicado: (2021)

Glycosphingolipids and neuroinflammation in Parkinson’s disease
por: Belarbi, Karim, et al.
Publicado: (2020)

Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
por: Bougea, Anastasia, et al.
Publicado: (2023)

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)

MCEE Mutations in an Adult Patient with Parkinson’s Disease, Dementia, Stroke and Elevated Levels of Methylmalonic Acid
por: Andréasson, Mattias, et al.
Publicado: (2019)

Reduction of spontaneous cortical beta bursts in Parkinson’s disease is linked to symptom severity
por: Vinding, Mikkel C, et al.
Publicado: (2020)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

A replication study, systematic review and meta-analysis of automated image-based diagnosis in parkinsonism
por: Papathoma, Paraskevi-Evita, et al.
Publicado: (2022)

Lipidomics of Glycosphingolipids
por: Farwanah, Hany, et al.
Publicado: (2012)

Attenuated beta rebound to proprioceptive afferent feedback in Parkinson’s disease
por: Vinding, Mikkel C., et al.
Publicado: (2019)

Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands
por: Singla, Akshi, et al.
Publicado: (2023)

GM1 Is Cytoprotective in GPR37-Expressing Cells and Downregulates Signaling
por: Hertz, Ellen, et al.
Publicado: (2021)

Immune dysfunction in Niemann‐Pick disease type C
por: Platt, Nick, et al.
Publicado: (2015)

Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2014)

Defining the glucosylceramide population of C. elegans
por: Xatse, Mark A., et al.
Publicado: (2023)

ARF6 Regulates Neuron Differentiation through Glucosylceramide Synthase
por: Li, Lu, et al.
Publicado: (2013)

Glycosphingolipids in human parasites
por: Cummings, Richard D.
Publicado: (2023)

Polyneuropathy in Gaucher disease type 1 and 3 – a descriptive case series
por: Andréasson, Mattias, et al.
Publicado: (2019)

Ceramides and glucosylceramides are independent antagonists of insulin action
por: Chavez, Jose A, et al.
Publicado: (2012)

Correction: Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2015)

Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
por: Barnes, Sonya, et al.
Publicado: (2014)

Characterization of moose intestinal glycosphingolipids
por: Johansson, Miralda Madar, et al.
Publicado: (2015)

Lyso-glycosphingolipids: presence and consequences
por: van Eijk, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n01bvd707k66o579podof99766